跳至主要内容
临床试验/NCT05749536
NCT05749536已完成不适用

Procaterol in Elite Athletes - a PK Study

Bispebjerg Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
urine concentration of drug 0-24 h

研究概览

简要总结

The purpose of the study is to find blood and urine concentrations of procaterol administrated either by inhalation or by tablets in asthmatic and non-asthmatics males. We hypotheis that the concentrations of procaterol in the blood and serum is higher after tablet intake versus inhalation.

详细描述

Doping study

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Doctor diagnosed asthma for the asthmatic group
  • GINA 1-3 for the asthmatic group
  • Use of beta2-agonist for at least 12 months for the asthmatic group
  • age 18-45
  • informed consent

排除标准

  • smoker or former smoker
  • airway infection to weeks prior to the study or during the study
  • other chronic diseaes than asthma and allergy
  • Use of beta2-agonist 6 days prior to the study
  • Allergy to the study medicine

结局指标

主要结局

urine concentration of drug 0-24 h

时间窗: 7 days

In healthy subjects to investigate drug farmakokenetic

serum concentration of drug 0-24 h

时间窗: 7 days

In healthy subjects to investigate drug farmakokenetic

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vibeke Backer

professor

Bispebjerg Hospital

研究点 (1)

Loading locations...

相似试验